Disease detection and classification in temporal lobe epilepsy: step-wise versus simultaneous AI decision models in a multisite neuroimaging study
Source check: Source checked. Not independent scientific confirmation.
Finding: A multisite study of 3,676 participants across 26 sites found that a staged model strategy—first detecting temporal-lobe epilepsy, then lateralizing the focus—performed better than simultaneous detection and lateralization. This is a retrospective neuroimaging result; it does not establish prospective clinical decision benefit.
Technology: AI models classify temporal lobe epilepsy and lateralize the epileptogenic focus from neuroimaging using sequential or simultaneous decisions.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- AI models classify temporal lobe epilepsy and lateralize the epileptogenic focus from neuroimaging using sequential or simultaneous decisions.
- Test and result
- The study compared sequential and simultaneous AI decision strategies across 26 sites and 3,676 participants.
- Limitation / still unknown
- Retrospective multisite evaluation; prospective workflow impact and patient outcomes were not assessed.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://europepmc.org/articles/PMC13421366
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary full text, including Methods and Results; publication date and first result-bearing version checked..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.